Bone Marrow TransplantationTissue DonorsHistocompatibility TestingTransplantation, HomologousGraft vs Host DiseaseBone MarrowHistocompatibilityBone Marrow CellsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationAnemia, AplasticTransplantation ConditioningTransplantation, AutologousLeukemiaAcademies and InstitutesSurvival AnalysisHematopoietic Stem Cell TransplantationBone and BonesHematopoietic Stem CellsGraft RejectionHLA AntigensLeukocyte TransfusionRadiation ChimeraTransplantation, IsogeneicLiver TransplantationGraft Enhancement, ImmunologicTransplantation ToleranceImmunosuppressionBone Marrow PurgingRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLTreatment OutcomeKidney TransplantationTime FactorsBone Marrow DiseasesImmunosuppressive AgentsBusulfanPediatricsSkin TransplantationAcute DiseaseSocieties, MedicalTransplantation ImmunologyLymphocyte DepletionGraft vs Host ReactionT-LymphocytesBone Marrow ExaminationChimerismCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisActuarial AnalysisLiving DonorsHeart TransplantationTissue and Organ ProcurementHematologic NeoplasmsBone Marrow NeoplasmsBlood DonorsCombined Modality TherapyLeukemia, Myeloid, AcuteRetrospective StudiesRemission InductionDisease-Free SurvivalLymphocyte Culture Test, MixedChimeraHepatic Veno-Occlusive DiseaseLeukemia, MyeloidMice, Inbred BALB CColony-Forming Units AssayBone RemodelingUnited StatesStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionMyelodysplastic SyndromesCord Blood Stem Cell TransplantationSevere Combined ImmunodeficiencyNeurologySurvival RateCell DifferentiationAfrican AmericansHematologic DiseasesFlow CytometryFollow-Up StudiesLung TransplantationCyclosporineMice, Inbred C3HPancytopeniaBone DensitySpleenAntineoplastic Combined Chemotherapy ProtocolsImmune ToleranceNuclear FamilyLeukocyte CountNational Academy of Sciences (U.S.)Organ TransplantationCarmustineCells, CulturedGranulocyte Colony-Stimulating Factor